New VC identifies unmet healthcare needs
Edge Medical Ventures approaches large global medical-device makers with one simple question: ‘What do you need?’
Edge Medical Ventures approaches large global medical-device makers with one simple question: ‘What do you need?’
AI firms now account for 30% of the nation’s 7,000-plus startups but are bringing in 47% of all investment.
Israeli participants at Climate Week and Israeli American Council Summit say the Startup Nation brand is still strong.
AI startup Jeen.ai emerges from stealth mode, offering enterprise-grade generative AI solutions.
Unicamel will focus on investing in early-stage startups in the deep tech field.
The newly launched CoC is a non-governmental grassroots initiative to strengthen ties between the Western US state and the Holy Land.
Flint Capital venture capitalist says the war has shown global investors the incredible resilience of the tech ecosystem in Israel.
A combination of environmental challenges and a new global appetite for sustainable food sources is making insect protein an increasingly viable alternative for animals and humans alike.
Eretz Angels will support startups in agricultural value chains, water, energy, health, biotech, recycling, smart manufacturing and more.
Over nine months into the Gaza war, professionals and a few international visitors are still connecting, building and working to make things happen at a host of AI and cybertech events.
The ‘smart antibody’ maker will receive $10 mil. in the initial stage of the agreement to develop molecules that would be used in anti-cancer drugs.
Greeneye Technology’s precision spraying can offer farmers in and around Nebraska a major productivity boost.
New startup Seven AI wins $36 million in funding for its software that reinvents the command center that monitors an organization’s IT infrastructure.
Kachol Balev matches war-affected companies in Israel with remote volunteers skilled in programming, software engineering, sales, marketing and more.
By combining software with traditional pharmaceuticals, Remepy’s hybrid drugs promise personalized and more effective treatments for cancer, Parkinson’s and more.